Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11458149 TEAD inhibitors and uses thereof

Patent 11458149 was granted and assigned to Ikena Oncology on October, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ikena Oncology

Current Assignee

Ikena Oncology

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11458149

Date of Patent

October 4, 2022

Patent Application Number

16887083

Date Filed

May 29, 2020

Patent Citations

‌

US Patent 10314823 Substituted 1,2-dihydro-3H-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds

‌

US Patent 10023558 Compounds

‌

US Patent 10160769 Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

‌

US Patent 11274082 Tead inhibitors and uses thereof

Patent Citations Received

‌

US Patent 12103915 TEAD inhibitors and methods of uses thereof

‌

US Patent 11760728 Tead inhibitors and uses thereof

‌

US Patent 11827634 Small molecule inhibitors of NF-kB inducing kinase

‌

US Patent 11925651 TEAD inhibitors and uses thereof

Patent Primary Examiner

‌

My-Chau T. Tran

The present invention provides compounds, compositions thereof, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11458149 TEAD inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API